Foresite Capital Opportunity Management V, LLC - GEMINI THERAPEUTICS INC ownership

GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 46 filers reported holding GEMINI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.

Quarter-by-quarter ownership
Foresite Capital Opportunity Management V, LLC ownership history of GEMINI THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$3,994,000
-2.9%
2,435,1250.0%11.99%
+15.6%
Q2 2022$4,115,000
+21.6%
2,435,1250.0%10.37%
+118.8%
Q1 2022$3,385,000
-52.2%
2,435,1250.0%4.74%
-0.2%
Q4 2021$7,086,0002,435,1254.75%
Other shareholders
GEMINI THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 2,435,125$9,838,0003.06%
Asymmetry Capital Management, L.P. 284,079$1,148,0000.69%
Orbimed Advisors 5,826,224$23,538,0000.26%
Boxer Capital, LLC 1,300,000$5,252,0000.18%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,137,823$8,637,0000.15%
Ikarian Capital, LLC 421,050$1,701,0000.12%
JS Capital Management LLC 474,457$1,917,0000.11%
PURA VIDA INVESTMENTS, LLC 494,400$1,997,0000.06%
HARVARD MANAGEMENT CO INC 250,000$1,010,0000.06%
Atom Investors LP 102,792$415,0000.03%
View complete list of GEMINI THERAPEUTICS INC shareholders